186 related articles for article (PubMed ID: 7308269)
21. Steady state absorption kinetics and pharmacodynamics of furosemide in congestive heart failure.
Chaturvedi PR; O'Donnell JP; Nicholas JM; Shoenthal DR; Waters DH; Gwilt PR
Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):123-8. PubMed ID: 3557737
[TBL] [Abstract][Full Text] [Related]
22. Acetylsalicylic acid suppresses the renal hemodynamic effect and reduces the diuretic action of furosemide in cirrhosis with ascites.
Planas R; Arroyo V; Rimola A; Pérez-Ayuso RM; Rodés J
Gastroenterology; 1983 Feb; 84(2):247-52. PubMed ID: 6401254
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of reduced effects of loop diuretics in healthy volunteers and in patients with renal disease.
Sjöström P
Scand J Urol Nephrol Suppl; 1988; 111():1-66. PubMed ID: 3201162
[TBL] [Abstract][Full Text] [Related]
24. Effect of furosemide in congestive heart failure.
Nomura A; Yasuda H; Minami M; Akimoto T; Miyazaki K; Arita T
Clin Pharmacol Ther; 1981 Aug; 30(2):177-82. PubMed ID: 7249502
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the diuretic effect of furosemide mixed with human albumin or fresh frozen plasma for patients with hypoalbuminemia in the intensive care unit.
Hsu CW; Lin SL; Sun SF; Chu KA; Chung HM; Chang HW
J Nephrol; 2006; 19(5):621-7. PubMed ID: 17136691
[TBL] [Abstract][Full Text] [Related]
26. Increased nonrenal clearance and increased diuretic efficiency of furosemide in cystic fibrosis.
Alván G; Beermann B; Hjelte L; Lind M; Lindholm A; Strandvik B
Clin Pharmacol Ther; 1988 Oct; 44(4):436-41. PubMed ID: 3168395
[TBL] [Abstract][Full Text] [Related]
27. Effect of intravenous infusion time on the pharmacokinetics and pharmacodynamics of the same total dose of furosemide.
Lee MG; Li T; Chiou WL
Biopharm Drug Dispos; 1986; 7(6):537-47. PubMed ID: 3828484
[TBL] [Abstract][Full Text] [Related]
28. The pharmacokinetics and pharmacodynamics of furosemide in anesthetized dogs with normal and experimentally decreased renal function.
Miyazaki H; Hirai J; Taneike T
Nihon Juigaku Zasshi; 1990 Apr; 52(2):265-73. PubMed ID: 2348592
[TBL] [Abstract][Full Text] [Related]
29. Clinical pharmacokinetics and pharmacodynamics of torasemide.
Knauf H; Mutschler E
Clin Pharmacokinet; 1998 Jan; 34(1):1-24. PubMed ID: 9474471
[TBL] [Abstract][Full Text] [Related]
30. Preliminary evaluation of furosemide-probenecid interaction in humans.
Smith DE; Gee WL; Brater DC; Lin ET; Benet LZ
J Pharm Sci; 1980 May; 69(5):571-5. PubMed ID: 7381747
[TBL] [Abstract][Full Text] [Related]
31. Effects of probenecid on furosemide kinetics and natriuresis in man.
Honari J; Blair AD; Cutler RE
Clin Pharmacol Ther; 1977 Oct; 22(4):395-401. PubMed ID: 902452
[TBL] [Abstract][Full Text] [Related]
32. Naloxone increases water and electrolyte excretion after water loading in patients with cirrhosis and ascites.
Leehey DJ; Gollapudi P; Deakin A; Reid RW
J Lab Clin Med; 1991 Nov; 118(5):484-91. PubMed ID: 1940589
[TBL] [Abstract][Full Text] [Related]
33. Comparative pharmacodynamics of furosemide and muzolimine in cirrhosis. Study on renal sodium and potassium handling and renin-aldosterone axis.
Bernardi M; De Palma R; Trevisani F; Santini C; Servadei D; Gasbarrini G
Z Kardiol; 1985; 74 Suppl 2():129-34. PubMed ID: 3890391
[TBL] [Abstract][Full Text] [Related]
34. Diuretic effect and disposition of furosemide in cystic fibrosis.
Prandota J; Smith IJ; Hilman BC; Wilson JT
Eur J Clin Pharmacol; 1991; 40(4):333-41. PubMed ID: 2050167
[TBL] [Abstract][Full Text] [Related]
35. Furosemide kinetics and dynamics after kidney transplant.
Smith DE; Gambertoglio JG; Vincenti F; Benet LZ
Clin Pharmacol Ther; 1981 Jul; 30(1):105-13. PubMed ID: 7016396
[TBL] [Abstract][Full Text] [Related]
36. Influence of probenecid and spironolactone on furosemide kinetics and dynamics in man.
Homeida M; Roberts C; Branch RA
Clin Pharmacol Ther; 1977 Oct; 22(4):402-9. PubMed ID: 902453
[TBL] [Abstract][Full Text] [Related]
37. [Comparative study of pharmacokinetics and effects on urinary secretion of electrolytes of furosemide and furosemide-amiloride in healthy subjects].
Kantelip JP; Aiache JM; Beyssac E; Abella ML
Therapie; 1991; 46(6):475-9. PubMed ID: 1819153
[TBL] [Abstract][Full Text] [Related]
38. Kinetics and dynamics of triamterene at steady-state in patients with cirrhosis.
Dao MT; Villeneuve JP
Clin Invest Med; 1988 Feb; 11(1):6-9. PubMed ID: 3365882
[TBL] [Abstract][Full Text] [Related]
39. Effects of the rate and composition of fluid replacement on the pharmacokinetics and pharmacodynamics of intravenous furosemide.
Li T; Lee MG; Chiou WL
J Pharmacokinet Biopharm; 1986 Oct; 14(5):495-509. PubMed ID: 3806372
[TBL] [Abstract][Full Text] [Related]
40. The pharmacokinetics and pharmacodynamics of the diuretic bumetanide in hepatic and renal disease.
Marcantonio LA; Auld WH; Murdoch WR; Purohit R; Skellern GG; Howes CA
Br J Clin Pharmacol; 1983 Feb; 15(2):245-52. PubMed ID: 6849758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
